What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
The scientist’s investigation covers issues in Internal medicine, Transplantation, Surgery, Hematopoietic stem cell transplantation and Immunology.
His Internal medicine research includes elements of Gastroenterology and Oncology.
His Oncology research is multidisciplinary, relying on both European LeukemiaNet and Imatinib mesylate.
His work carried out in the field of Transplantation brings together such families of science as Retrospective cohort study, Chronic myelogenous leukemia, Stem cell and Bone marrow.
His research in Surgery focuses on subjects like Multiple myeloma, which are connected to Autogenous bone and Marrow transplantation.
The study incorporates disciplines such as Hematopoietic stem cell, Cord blood and Hazard ratio in addition to Hematopoietic stem cell transplantation.
His most cited work include:
- Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia (2888 citations)
- Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia (2837 citations)
- Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet (1080 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Immunology and Surgery.
He has included themes like Gastroenterology and Oncology in his Internal medicine study.
Alois Gratwohl interconnects Imatinib and Myeloid leukemia in the investigation of issues within Oncology.
His research investigates the connection with Transplantation and areas like Stem cell which intersect with concerns in Cord blood.
Alois Gratwohl combines subjects such as Hematopoietic stem cell, Framingham Risk Score, Cohort and Intensive care medicine with his study of Hematopoietic stem cell transplantation.
Much of his study explores Immunology relationship to Cytotoxic T cell.
He most often published in these fields:
- Internal medicine (55.49%)
- Transplantation (45.45%)
- Hematopoietic stem cell transplantation (35.98%)
What were the highlights of his more recent work (between 2010-2021)?
- Internal medicine (55.49%)
- Transplantation (45.45%)
- Hematopoietic stem cell transplantation (35.98%)
In recent papers he was focusing on the following fields of study:
Alois Gratwohl mostly deals with Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Oncology.
Internal medicine and Gastroenterology are frequently intertwined in his study.
His Transplantation research is multidisciplinary, incorporating perspectives in Haematopoiesis, Stem cell and Pediatrics.
His biological study spans a wide range of topics, including Retrospective cohort study, Immunology, Cohort and Intensive care medicine.
The various areas that he examines in his Surgery study include Immunosuppression and Hazard ratio.
Alois Gratwohl has researched Oncology in several fields, including Blast Phase, Multiple myeloma and Drug.
Between 2010 and 2021, his most popular works were:
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis: A Randomized Clinical Trial (374 citations)
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach (275 citations)
- Cytarabine dose for acute myeloid leukemia. (270 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary areas of investigation include Internal medicine, Transplantation, Hematopoietic stem cell transplantation, Surgery and Immunology.
His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine.
His Transplantation research is multidisciplinary, incorporating elements of Unrelated Donor, Haematopoiesis, Cord blood and Intensive care medicine.
His studies in Hematopoietic stem cell transplantation integrate themes in fields like Hematopoietic stem cell, Cohort and Hazard ratio.
His research ties Oncology and Surgery together.
The Immunology study combines topics in areas such as Transplantation Conditioning, Toxicity and Haplotype.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
